Contacts
Investor Contact
Kaitlyn Brosco
Kbrosco@vicarioussurgical.com
Marissa Bych
Gilmartin Group
Marissa@gilmartinir.com
Press and Media Inquiries:
Abby Mayo for Matter Health
media@vicarioussurgical.com
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE:RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the Company will participate in the Canaccord Genuity 43rd Annual Growth Conference.
Management is scheduled to present on Wednesday, August 9 at 2:30 p.m. ET. A live webcast of the presentation will be accessible to the public on the “Investors” section of the Company’s website at https://investor.vicarioussurgical.com. An archive of the webcast will be available for replay following the conference.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230803405108/en/
Related news for (RBOT)
- Vicarious Surgical Announces Planned Retirement of Chief Operating Officer
- Vicarious Surgical Announces Departure of Chief Financial Officer
- Vicarious Surgical Reports Q4 and FY 2023 Financial Results
- Vicarious Surgical Reports Third Quarter 2023 Financial Results
- Vicarious Surgical Receives Continued Listing Standard Notice From NYSE